Recent Report Covers Upcoming Opportunities in Bioburden Testing Market

Bioburden is defined as the number in terms of percentage, colony or cell count of bacteria that thrive on a given unsterilized surface. Bioburden testing, also known as microbial limit testing provides quantification of the bacterial cell cultures on a given unsterilized surface. The major application of bioburden testing lies in implant fixation procedures that require testing ofcertain tolerable bioburden limit before implantation in the human body. The standard for bioburden testing in the US is regulated by the US FDA, whereas global standards are maintained by the ISO (International Organization for Standardization). The quantification for the standardization process is done in terms of colony forming unit (CFU). Bioburden testing is essential in limiting the presence of infection causing bacteria in an object that is to be integrated into a human body as an implant. The testing is important to eliminate the presence of bacterial residue and growth in any object present in natural state. In addition it is almost impossible to remove bacterial residue permanently in an object that is liable to be exposed to open air. Hence sterilization process is performed on an implant object or a device post understanding the bioburden limit. This helps to select the appropriate sterilization technique in order to remove the bacterial burden just prior to the medical (Or other related) procedure. Bioburden testing has therefore saved numerous lives.

Obtain Report Details @ http://www.transparencymarketresearch.com/bioburden-testing-market.html

Based on technology, bioburden testing is segmented into microbial filter method, advanced colorimetric method, and plate count method. Among these, microbial filter method is the most commonly used method for bioburden testing procedures. The plate count method is among the oldest methods for bioburden testing, however is not used regularly on a large scale commercial basis due to its time consuming procedure. Advanced colorimetric method is presently the most promising and widely used bioburden testing technology. The congregation of colometer and computational capabilities has enabled advanced colometric methods to deliver quick results of quantifying bioburden.

Based on equipment, bioburden testing market can be segmented into PCR (polymerase chain reaction) instruments, cell counters, and automated microbial identification systems that are software integrated. Application segment for bioburden testing includes healthcare, aerospace (satellite production & development), supercomputer (super- microprocessor manufacturing) designing, and others (raw material, equipment cleaning, food & beverage). The healthcare industry is the largest application area of bioburden testing.

Geographically, the bioburden testing market is primarily concentrated in the North America and Asia Pacific region. The demand for bioburden testing in the Asia Pacific region is expected to grow, and very likely to replace the North America market soon. Australia, Japan, and China form the largest markets in the Asia Pacific region. South Asia and South East Asia on the other hand show great potential in terms of life sciences and raw material applications; although at present a majority of the growing bioburden testing market consists of life science applications. Besides this, a large number of contract manufacturers reside in the Asia Pacific region. On the other hand, European industries continue to remain a strong point in the global bioburden testing market mainly due to the high quality of products services offered, presence of numerous quality manufacturers and their increased reliability. However certain significant restrictions for bioburden testing remains valid in the European and North American region, such as dearth of trained technicians, overwhelming volume of service demand, and high cost of services, to name a few. The bio-burden testing market in the Rest of the World (ROW) region is expected to grow at a steady rate, albeit slower than the major economies of the world.

Fill the Form to Gain Deeper Insights on this Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4669

Some of the well known manufacturers/service providers of bioburden testing equipment/service include: Charles River Laboratories International, Inc., Sigma-Aldrich Corporation, SGS S.A., WuXi PharmaTech (Cayman), and Inc., Merck & Co., Inc., Becton, Dickinson and Company, North American Science Associates, Inc., Nelson Laboratories, Pacific Biolabs, and ATS Labs, Inc.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America

  • Asia Pacific

  • Europe

  • Middle East and Africa

  • Latin America

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Antithrombin (recombinant) Market: Upcoming Demands and Growth Analysis

Global Antithrombin Market: Overview

Antithrombotic drugs help in the prevention or inhibition of thrombus by mimicking the role of antithrombin, a protein molecule produced in our body which helps in clotting. The protein molecule is produced by the liver, and among other benefits, has anti-inflammatory effects. Engineered recombinant antithrombin has gained clinical significant in recent years for the prevention of various peri-partum and peri-operative thromboembolic events or blood clots.

A notable development in the market has been the U.S. FDA approval of ATryn in 2009. The molecule, a recombinant Antithrombin, has been manufactured by rEVO Biologics and has been useful in treating patients suffering from hereditary antithrombin (AT) deficiency undergoing surgery or giving birth. However, the treatment is not yet approved for indications in patients suffering from hereditary antithrombin deficient. Several clinical studies and developments of novel targeted therapies are ongoing and boost the evolution of the Antithrombin market.

Obtain Report Details @ http://www.transparencymarketresearch.com/antithrombin-market.html

The report provides comprehensive insights into the key market dynamics, emerging trends, opportunities, research and development activities, regulatory landscape, and competitive dynamics. The study is an indispensable guide for all market participants exploring imminent investment pockets in various regions as they can capitalize on lucrative market avenues.

Global Antithrombin Market: Trends and Opportunities

Managing the right level of the coagulation protein antithrombin in human body is essential. The deficiency of the protein may be fatal and is prominent in case of patients suffering from an inherited deficiency, a genetic rare disease. The growing prevalence of this disease, both among men and women, is a key factor propelling the demand for antithrombin drugs and therapies. The recent FDA approval of recombinant antithrombins in major region has increasingly boosted the market. The protein molecules have also gained importance to boost the levels of Antithrombin in patients. This deficiency is attributed to clinical conditions prevalent in patients affected by liver failure, metastatic tumors, severe trauma, and nephritic syndrome. Moreover, patients undergoing heparin therapy and chemotherapy may also suffer from antithrombin deficiency. These factor are expected to catalyze the market growth over the forecast period.

However, the limited efficacy of antithrombin to improve neonatal outcomes is likely to impede the market to an extent. Furthermore, ATryn, the recently approved recombinant antithrombin by U.S. FDA, is found to have contraindications in patients who have hypersensitivity to goat milk proteins. Nevertheless, recent advances in clinical studies in evaluating the potential of recombinant antithrombins in prolonging gestation so as to improve maternal and neonatal outcomes have opened up exciting opportunities for market players.

Global Antithrombin Market: Regional Outlook

The major regional markets for antithrombin are North America, Europe, and Asia Pacific. Of these, North America is a prominent market and is trailed by Europe. The substantial growth in these regional markets is attributed to the early adoption of recombinant antithrombins in preventing various clinical conditions caused by the prevention of blood clots.

However, Asia Pacific is projected to witness a robust demand for recombinant antithrombins. This regional market is chiefly driven by the surge in demand from the countries such as India and China. In addition, the growing incidence of various cardiovascular diseases is expected to propel the demand for recombinant antithrombins in various countries of Asia Pacific.

Fill the Form to Gain Deeper Insights on this Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4500

Companies mentioned in the report

Key companies operating in the antithrombin (recombinant) market include rEVO Biologics Inc., Ovation Pharmaceuticals, and GTC Biotherapeutics Inc. In the coming years, the market is expected to witness several large pharmaceutical companies making a foray in the biotechnology segment. They intend to make intensive research and development in biotechnology to gain a foothold in the market in various regions. This is likely to intensify the competition in the global antithrombin (recombinant) market over the forecast period.

Major regions analyzed under this research report are:

  • North America

  • Europe

  • Asia Pacific

  • Rest of the World

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Imaging Biomarkers Market: Global Industry Analysis by 2023 & Growth Opportunities

An imaging biomarker is a biomarker that can be detected with the help of an imaging technology. Biomarkers are increasingly being applied as a diagnostic tool. These are an objective measure for the level of activities of genes, proteins and other molecular features. According to the National Institutes of Health’s National Cancer Institute, biomarker is a biological molecule found in tissue, blood or other body fluids, which mark the presence of a normal or an abnormal process, or of a condition or disease. Therefore, biomarkers are more useful to detect and monitor responses of the body to a disease or condition. Since cancer is associated with alterations in the status and expression of multiple genes, technologies are under development that could provide important insights into the etiology of the cancer and be vital to detect, diagnose, and treat cancer. Biomarkers, help in early detection of cancer, resulting in increased survival rate among cancer patients.

Obtain Report Details @ http://www.transparencymarketresearch.com/imaging-biomarkers-market.html

The global imaging biomarkers market is segmented on the basis of imaging technologies, applications and geography. Imaging technologies include positron emission tomography (PET), ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and single-photon emission computed tomography (SPECT). Personalized medicines, drug discovery and development, molecular diagnostics, drug formulation, disease diagnosis and forensic applications are the major application segments for imaging biomarkers. Determination of disease mechanisms, toxicity profiling, and in target discovery and validation are some of the key drivers propelling the demand for imaging biomarkers.

MRI procedures use magnetic field and are thus safer than other imaging techniques such as CT and PET scan. Multi parametric MRI is emerging as an improved technique and best imaging modality for localizing and staging of various cancers. PET scanners due to their high cost, have their usage limited to large hospitals. These are useful in cancer staging and to determine the preseance of metastasis. It is estimated that approximately 95% of all PET procedures performed are related to cancers and is the normal standard of care in the diagnosis, staging and determining treatment of cancer patients. Technologically advanced imaging modalities such as PET/MR, provide new tools for biomarker imaging by combining morphological and molecular imaging. Present day CT equipment produce 3D images by capturing pictures in a helical (or spiral) way and the most recent equipment have the ability to take more images in a very short time. In certain cases, contrast medium dyes are used during imaging for clear visualization of tissues. Ultrasound imaging has gained popularity along with mammogram for detecting breast cancer, as it is non-invasive, cost effective, and is widely available.

Fill the Form to Gain Deeper Insights on this Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2381

Geographically, the global imaging biomarkers market can be categorized into four major regions namely North America, Europe, Asia Pacific and Rest of the World. North America comprising of the U.S. and Canada dominates the global imaging biomarkers market followed by the European countries due to well established healthcare infrastructure in these regions. Emerging economies in the Asia Pacific region are expected to be the fastest growing region in the near future due to rising awareness regarding the imaging biomarkers and continuous improvement in the healthcare infrastructure. Various organizations have been formed in order to assist in biomarkers discovery and their assessment in drug development and response to therapy. These organizations include The Biomarkers Consortium, International Cancer Biomarker Consortium and The Predictive Safety Testing Consortium. Abbott Laboratories, Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Becton, Dickinson and Company, Affymetrix Inc., Danaher Corporation, Qiagen NV, DiagnoCure, Inc., Gen-Probe Inc., F. Hoffmann La Roche Ltd., and Siemens Healthcare.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America

  • Asia Pacific

  • Europe

  • Rest of the World

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Recent Report Covers Upcoming Opportunities in Dental Compressors Market

Global Dental Compressors Market: Overview

Dental compressors pressurize surrounding air to be used in dental procedures. Compressed air quality is dependent on inlet air and the air quality in the compressor. Most dental compressors have a dryer to eliminate moisture. The two common types of dryers included in dental compressors are desiccant and membrane.

Dental compressors are gauged from their air compressing capacity, which is a combination of volume output, duty cycle, and chamber size. Capacity and reliability of compressors is related as several compressors have a limited duty cycle – the uptime that a compressor is functional without cooling off.

Dental compressors have heads, each of which has one or more pistons. While some models have a single head, others employ a multihead design. Heads used in compressors should be made of good quality materials and designed to eliminate heat. Components should be serviceable and should not need to be replaced in the event of a breakdown. For instance, antifriction coatings such as Teflon is extensively used to minimize piston wear.

Obtain Report Details @ http://www.transparencymarketresearch.com/dental-compressors-market.html

The publication on the global dental compressors market presents insights into market indicators, growth trends, and product developments that are important to comprehend the growth curve of the said market over the forecast period. The market study presents market size estimates and revenue projections based on past performance and current figures. The analysis presented in the market study helps existing as well as new players formulate gainful competitive strategies to stay ahead in the competition.

Global Dental Compressors Market: Trends and Opportunities

Across the world, increasing awareness about the importance of oral health and the consequent increase in number of dental procedures is the primary factor driving the dental compressors market. As per the World Health Organization, 60%-90% of children in their school years and almost 100% adults have dental cavities.

Furthermore, increasing unhealthy practices such as smoking, consumption of tobacco leading to oral health problems is also driving the market’s growth. The increasing prevalence of gum diseases due to a host of reasons such as age, poor brushing practices, etc. is also aiding growth of the dental compressors market. As per the Centers for Disease Control and Prevention, almost 4%-6% adults are affected by advanced gum disease in the U.S. each year.

Global Dental Compressors Market: Regional Outlook

The global dental compressors market is divided into four broad regions, namely North America, Asia Pacific, Europe, and Rest of the World (RoW). Amongst these, North America is the leading regional market for dental compressors followed by Europe. In these regions, a high level of awareness for dental health leading to an increasing demand for dental procedures such as filling, bonding, crowns and caps, etc. combined with an increasing prevalence of oral diseases is driving the dental compressors market.

Asia Pacific is expected to emerge as one of the most lucrative markets for dental compressors. This is due an increasing population with dental health problems, increasing spending on health and well-being, and increasing awareness about the importance of oral health among the urban population of China and India.

Fill the Form to Gain Deeper Insights on this Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4478

Global Dental Compressors Market: Competitive Landscape

Some of the key players in the global dental compressors market are Kaeser Dental, Metasys, Gnatus, Air Techniques Inc., Ritter Dental USA, Fedesa, Midmark, DÜRR DENTAL AG, Mestra, Cattani S.p.A., and Diplomat Dental Solutions among others.

Each of the companies is profiled for their distinguishing business attributes of product portfolio, competitive standing, and financials.

The global dental compressors market is segmented as follows:

Global Dental Compressors Market, by Region

  • North America

  • Asia Pacific

  • Europe

  • Rest of the World

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Recent Report Covers Upcoming Opportunities in Inferior Vena Cava (IVC) Filters Market

Inferior Vena Cava (IVC) Filters are small, cage like devices and commonly used to capture blood clots into the inferior vana cava. These medical devices are inserted into inferior vana cava in order to prevent risk of pulmonary emboli and to prevent them from reaching to the lungs. Inferior vana cava is the main vessel that returns blood from the lower half of the body to the heart. Inferior vana cava filters are usually placed in the patient when anticoagulant therapy cannot be effective at the risk of pulmonary embolism. Commercially these filters are available either to implant permanently or temporarily.

Obtain Report Details @ http://www.transparencymarketresearch.com/vena-cava-filters-market.html

The market of inferior vana cava filters is majorly driven by rising incidences of cardiovascular diseases globally. According to World Health Organization, about 17.3 million people died from cardiovascular disease (CVD) in 2008 and the number is expected to reach 23.3 million by 2030. This increase in number of patients diagnosed with cardiovascular diseases across the world will boost the global inferior vena cava filters market. In addition, positive initiatives by government and private organization to increase awareness about this device will drive the market growth of inferior vena cava filters. For example, in May 2014, U.S. Food and drug administration issued post market surveillance study for inferior vena cava filters. This study provides information about the implementation of these filters along with the risk of pulmonary embolism. Thus, these types of efforts will increase the uptake of inferior vena cava filters hence drives the market growth. Moreover, consistent launch of new products by key companies will further drive the market growth of inferior vana cava filters. For example, in January 2014, Argon Medical Devices, Inc. announced that the U.S.FDA has cleared Option ELITE retrievable inferior vena cava (IVC) filter. This device is featured with new over-the-wire delivery technique that enables physicians to safely deliver the filter to a patient’s inferior vana cava by following the path of a guide wire. Thus, these types of introduction will increase the acceptance of these devices and hence stimulates the market growth. However, high cost of the product will hamper the market growth in near future.

The market of global inferior vena cava filters can be segmented on the basis of:

By Types

  • Retrievable Inferior Vena Cava filters

  • Permanent Inferior Vena Cava filters

  • Others

Geographically, North America and Europe dominates the global inferior vena cava filters market due to increasing patient population suffering from cardiovascular diseases, lack of physical activity and unhealthy diet. Europe is considered as the second largest market of inferior vena cava filters. The growth of inferior vena cava filters market in Europe is majorly attributed to the aging population. According to Eurostat (European Commission) report published in 2013, around 17.8% of the European population were aged 65 years and above. In addition, India, South East Asia and China are the emerging markets for inferior vena cava filters because of positive initiative by government in Asia-Pacific regions toward healthcare infrastructure.

Fill the Form to Gain Deeper Insights on this Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1555

Various key players contributing to the global inferior vena cava filters market comprises Baxter International Inc., Fukuda Denshi Co., Ltd., Lidco Group Plc, Accellent, Inc., All Pro Corporation, Arterial Remodeling Technologiesuscome Limited, Biosensors International Group, Ltd., Fudan University Zhongshan Hospital, Cardiva Medical, Inc., 3M Healthcare, Abbott Laboratories and others.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America

  • Asia Pacific

  • Europe

  • Rest of the World

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Protein Characterization and Identification Market Research Report Forecast to 2015- 2023

Global Protein Characterization and Identification Market: Overview

Proteins form the fundamental component of human life and thus, they are an important subject of study and research. Protein characterization and identification is the basic research process to analyze the contents of a protein-based on their molecular weight and their charge. The demand for protein characterization and identification is high for clinical diagnosis, agricultural and environmental research, and drug discovery and development. The research process finds application across end-use sectors such as pharmaceutical, biotechnology, contract research organizations, and academic research institutes.

Obtain Report Details @  http://www.transparencymarketresearch.com/protein-characterization-identification-market.html

The report on the global protein characterization and identification market encompasses all the important parameters of the market and its affiliated industries. The key trends and opportunities presented in the report are useful for existing as well as new players in formulating viable growth strategies. Besides, the detailed coverage of business strategies and latest developments of the leading companies in the market makes the report a reliable business tool. The report also sheds light on market segmentation on the basis of various criteria, including geography and application.

Global Protein Characterization and Identification Market: Drivers and Restraints

To ensure sustainable growth, pharmaceutical and biotechnology companies are paying high attention to research and development activities. As a result, they are pouring large fund into such activities, which has a direct positive impact on the growth of the global protein characterization and identification market. In addition, rapid advancements in technology are facilitating improvements in research processes, thereby augmenting the market.

The robust growth of the biologics and proteomics sectors is also one of the key factors stoking the adoption of protein characterization and identification. Besides this, several governments worldwide are investing large sums in proteomics research, which is providing a fillip to the global market.

However, the high cost of instruments used in protein characterization and identification is acting as a major impediment to the growth of the market. Moreover, the dearth of skilled and qualified personnel is hindering the growth of the market. Nevertheless, the emergence of biomarkers along with the booming biomarker identification segment is rendering the global protein characterization and identification market highly lucrative.

Global Protein Characterization and Identification Market: Geographical Segmentation

The key regions reviewed in the report are Asia Pacific, North America, Europe, and Rest of the World. Asia Pacific will be a prominent market for protein characterization and identification. The region is a home to a large number of companies manufacturing biotechnological analytical devices. The increasing investments by governments of emerging economies in research and development activities are leading to the greater uptake of protein electrophoresis equipment in the region. The growth of APAC can also be attributed to the easy availability of raw materials and reagents. Japan and China will be major revenue contributors to the growth of the market. Europe will also represent a large share in the market during the forecast period, with France and the U.K. being sights of high growth rate.

Fill the Form to Gain Deeper Insights on this Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4501

Global Protein Characterization and Identification Market: Competitive Landscape

The global protein characterization and identification market is a highly fragmented arena in nature. Research and development play a vital role in the protein characterization and identification industry. Therefore, companies are investing sizeable funds in these activities. In addition, players in the market are looking upon mergers and acquisitions as a viable strategy to enhance their research facilities. Some of the key participants in the global marketplace are Proteome Factory AG, CBS Scientific Company Inc., AB Sciex Pte. Ltd, Alphalyse Inc., LabRepCo., Serva Electrophoresis GmbH., Lonza Group Ltd, Sigma-Aldrich Co. LLC., and Hoefer Inc.

Major regions analyzed under this research report are:

  • Europe

  • North America

  • Asia Pacific

  • Rest of the World

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Resectoscopes Market: Upcoming Demands and Growth Analysis

Resectoscopes are surgical instruments used in procedures of uterus, prostate, bladder, or urethra. Resectoscopes are primarily used for tissue extraction and removal of masses or growths (fibroids) and damaged tissues. Resectoscopes comprise a camera (such as a wide angle microscope) and extraction instrument (wire loop) which enables surgeons to visualize surgical site and perform surgery through the same incision. Use of resectoscopes in urogenital procedures decrease healing time, reduces surgical trauma, and provides minimally invasive treatment options for the patient.

Obtain Report Details @ http://www.transparencymarketresearch.com/resectoscopes-market.html

Increasing prevalence of urinary/urogenital diseases such as benign prostatic hyperplasia (BPH), urinary incontinence, urinary tract infection and hematuria have created immense demand for resection procedures and consequently for sophisticated resectoscopes. As per the U.S National Library of Medicine, 60% of men over the age of sixty and 80% of men over the age of 80 have been diagnosed as BPH patients who require transurethral resection of the prostate (TURP). Resectoscopes have been demonstrated to be efficient, cost-effective and, most importantly have a low rate of post surgical infections. Current technical advancements such as bipolar, roller ball, roller barrel and cutting loop electrodes, along with video-capabilities have substantially increased the acceptance of resectoscopes in surgical procedures. Visual, hands-on access to the surgical sites and immediate removal of excess tissue is some of the technical advancement of resectoscopes over other available equipment for visualization and removal of tissues. However, recent technological advances to reduce the invasive aspect of surgical treatments of urogenital diseases such as lasers, microwave, radio waves, Photoselective laser vaporization of the prostate (PVP) and ultrasound would restrain the resectoscopes market to some extent.

One perspective of analyzing the market is based on type of electrode used in resectoscopes. Monopolar, bipolar, grooved roller, roller ball, roller barrel and straight cutting loop are some major electrodes that are widely used in resectoscopes.

Based on geography, the resectoscopes market has been analyzed for North America, Asia-Pacific, Europe, and the Rest of the World (RoW). North America and Europe held the largest shares in terms of market revenue of the global resectoscopes market in 2013. The primary reasons for North America and Europe holding the leading positions in the global resectoscopes market are high prevalence of urogenital diseases such as BPH and benign prostatic obstruction (BPO), and well established healthcare infrastructure in both the regions. According to the American Urological Association, 15 million men in the United States are symptomatic to BPH and in the approximately 150,000 people have TURPs performed each year. However, Asia-Pacific is expected to witness highest growth rate during the forecast period from 2014 to 2020. A number of factors such as increasing prevalence of urinary tract infections, aging population, increasing focus on research and development would be fuelling the growth of resectoscopes market in Asia-Pacific in coming years. According to the Department of Economic and Social Affairs, United Nations, 23 million individuals aged 80 years or over were living in China in 2013. The Department of Economic and Social Affairs further states that nearly 10 million and 9 million individuals aged 80 years or over were living in India and Japan, respectively in 2013.

Fill the Form to Gain Deeper Insights on this Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4482

Some of the major players in resectoscopes market include Olympus Corporation, Richard Wolf, Stryker Corporation and KARL STORZ GmbH & Co. KG.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of

  • Market growth drivers

  • Factors limiting market growth

  • Current market trends

  • Market structure

  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/